Patient ID
|
Gender
|
Type
|
Primary tumor grade
|
Metastasis resectiona
|
Treatmentb
|
---|
Patient 1
|
Female
|
Adenocarcinoma
|
Moderately differentiated
|
3 months
|
No treatment
|
Patient 2
|
Male
|
Adenocarcinoma
|
Moderately differentiated
|
20 months
|
No treatment
|
Patient 3
|
Male
|
Adenocarcinoma
|
Poorly differentiated
|
10 months
|
XELOXc and Bevacizumab
|
Patient 4
|
Female
|
Adenocarcinoma
|
Well differentiated
|
9 months
|
5FU, leucovorin, oxaliplatin, bevacizumab
|
- aTime between primary resection and metastasis resection. bTreatment after primary tumor resection. cCapecitabine and oxaliplatin. 5FU, fluorouracil.